ZIOP ZIOPHARM Oncology, Inc. Stock Quote

ZIOP [NASD]

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	6.56%	Shs Outstand	212.84M	Perf Week	11.08%
Market Cap	733.10M	Forward P/E	-	EPS next Y	-0.41	Insider Trans	-1.44%	Shs Float	200.24M	Perf Month	24.03%
Income	-73.00M	PEG	-	EPS next Q	-0.10	Inst Own	55.40%	Short Float	16.68%	Perf Quarter	32.95%
Sales	-	P/S	-	EPS this Y	-173.40%	Inst Trans	-2.50%	Short Ratio	16.75	Perf Half Y	4.78%
Book/sh	0.68	P/B	5.16	EPS next Y	-10.80%	ROA	-44.60%	Target Price	-	Perf Year	-29.52%
Cash/sh	0.65	P/C	5.41	EPS next 5Y	-	ROE	-50.00%	52W Range	1.79 - 5.11	Perf YTD	39.29%
Dividend	-	P/FCF	-	EPS past 5Y	-17.40%	ROI	-	52W High	-31.31%	Beta	2.08
Dividend %	-	Quick Ratio	8.00	Sales past 5Y	-	Gross Margin	-	52W Low	95.54%	ATR	0.23
Employees	73	Current Ratio	8.00	Sales Q/Q	-	Oper. Margin	-	RSI (14)	67.64	Volatility	7.79% 7.47%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	78.00%	Profit Margin	-	Rel Volume	1.85	Prev Close	3.51
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 05 AMC	Payout	-	Avg Volume	1.99M	Price	3.51
Recom	2.20	SMA20	20.73%	SMA50	25.64%	SMA200	22.53%	Volume	3,695,988	Change	0.00%

Jun-19-20

Initiated

Jefferies

Buy

Mar-04-20

Initiated

Cantor Fitzgerald

Overweight

Aug-23-19

Resumed

Raymond James

Outperform

Apr-04-19

Initiated

Lake Street

Buy

Apr-01-19

Initiated

Laidlaw

Buy

$7.50

Nov-15-18

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-18-18

Downgrade

JP Morgan

Neutral → Underweight

Jun-01-17

Initiated

H.C. Wainwright

Buy

$9.50

Aug-10-16

Upgrade

Wells Fargo

Underperform → Market Perform

Jul-19-16

Reiterated

Mizuho

Neutral

$7 → $5

Jun-02-16

Initiated

Raymond James

Mkt Perform

May-11-16

Reiterated

Mizuho

Neutral

$6 → $7

Jan-25-16

Reiterated

Mizuho

Neutral

$10 → $6

Dec-04-15

Initiated

Wells Fargo

Underperform

Jun-10-15

Reiterated

Mizuho

Neutral

$14 → $10

Mar-10-15

Downgrade

Mizuho

Buy → Neutral

$14

Mar-02-15

Reiterated

Mizuho

Buy

$11 → $14

Mar-20-14

Initiated

Mizuho

Buy

$11

Apr-02-12

Reiterated

Griffin Securities

Buy

$9 → $12

Mar-26-12

Initiated

Canaccord Genuity

Buy

Jan-14-21 08:00AM	Ziopharm Oncology Announces Election of James Huang as Chairman of the Board of Directors GlobeNewswire +15.46%
Dec-23-20 04:01PM	Ziopharm to Participate in Upcoming January Conferences GlobeNewswire
05:14AM	Companies Like ZIOPHARM Oncology (NASDAQ:ZIOP) Are In A Position To Invest In Growth Simply Wall St.
Dec-22-20 07:45AM	The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes Benzinga +5.00%
Dec-21-20 04:01PM	Ziopharm Oncology Announces Clearance of Taiwans First IND of Non-viral CAR-T for the Treatment of Relapsed CD19+ Leukemias and Lymphomas GlobeNewswire
Dec-17-20 09:00AM	WaterMill Asset Management Issues Statement Regarding Consent Solicitation at Ziopharm Oncology Business Wire +7.61%
08:56AM	Are Options Traders Betting on a Big Move in Ziopharm (ZIOP) Stock? Zacks
Dec-16-20 04:01PM	Ziopharm Comments on Consent Solicitation Results GlobeNewswire
Dec-15-20 07:52AM	The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding Benzinga -8.41%
Dec-14-20 04:02PM	Ziopharm Oncology Announces Chief Financial Officer to Step Down GlobeNewswire +11.55%
12:06AM	Is ZIOP A Good Stock To Buy Now? Insider Monkey
Dec-12-20 05:15PM	WaterMill Asset Management Addresses Ziopharm Oncologys Latest Distortion and Recent Threat Business Wire
Dec-11-20 06:57PM	Ziopharm Comments on Delay of WaterMills Stated Consent Deadline GlobeNewswire
Dec-10-20 07:01PM	Egan-Jones Recommends Against Electing Dissidents Full Slate of Nominees to Ziopharm Board GlobeNewswire
Dec-08-20 09:00AM	WaterMill Asset Management Reinforces the Need for Meaningful and Urgent Change at Ziopharm Oncology Business Wire +5.86%
Dec-04-20 08:30AM	Ziopharm Details Actions in Response to Shareholder Feedback GlobeNewswire
Dec-02-20 10:04PM	Proxy firm Glass Lewis backs investor WaterMill's board nominees at Ziopharm Oncology Reuters
09:00PM	Glass Lewis Recommends Ziopharm Shareholders Vote on the WHITE Consent Card for All of WaterMills Director Candidates and Proposals Business Wire
Nov-28-20 05:30PM	WaterMill Asset Management Refutes Ziopharm Oncologys Desperate, Low-Road Smear Campaign Business Wire
Nov-27-20 05:32PM	Ziopharm Comments on Institutional Shareholder Services Recommendation to Reject WaterMills Attempt to Remove Half of Ziopharms Board of Directors GlobeNewswire
Nov-25-20 08:30PM	ISS Recommends Ziopharm Shareholders Vote for Change on WaterMill Asset Managements WHITE Consent Card Business Wire
07:36PM	ISS backs two of three of activist's board nominees at Ziopharm Oncology Reuters
Nov-24-20 09:00AM	WaterMill Asset Management Sets the Record Straight Following Ziopharms Apparent Attempt to Mislead Shareholders and Rewrite History Business Wire
Nov-20-20 11:00AM	Ziopharm Releases Investor Presentation Highlighting Execution of Strategy and Substantial Board Refreshment to Enhance Shareholder Value GlobeNewswire
Nov-19-20 09:30AM	WaterMill Asset Management Releases Presentation Detailing the Case for Urgent Change Atop Ziopharm Oncology Business Wire
09:00AM	Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Glioblastoma and DIPG at the 2020 Society for Neuro-Oncology Annual Meeting GlobeNewswire
09:00AM	White Rock Capital Supports WaterMill's Case for Change at Ziopharm Oncology PR Newswire
Nov-17-20 04:15PM	Ziopharm Oncology Appoints Raffaele Baffa, M.D., Ph.D., as Chief Medical Officer GlobeNewswire
Nov-16-20 08:30AM	Ziopharm Oncology Appoints Mary Thistle to Board of Directors GlobeNewswire
Nov-13-20 09:15AM	Ziopharm Oncology to Participate in Jefferies Virtual London Healthcare Conference on November 19, 2020 GlobeNewswire
Nov-12-20 09:00AM	WaterMill Asset Management Releases Candid Q&As with Each of its Director Candidates for Election to Ziopharm Oncologys Board Business Wire
Nov-06-20 10:31PM	Ziopharm Oncology Inc (ZIOP) Q3 2020 Earnings Call Transcript Motley Fool -7.44%
Nov-05-20 04:02PM	Ziopharm Oncology Reports Third Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
02:30PM	ZIOPHARM Oncology, Inc. to Host Earnings Call ACCESSWIRE
09:05AM	WaterMill Asset Management Sends Letter to Ziopharm Oncology Shareholders Business Wire
Nov-02-20 09:00AM	Ziopharm Files Definitive Consent Revocation Statement and Sends Letter to Shareholders GlobeNewswire +8.13%
08:45AM	WaterMill Asset Management Launches Consent Solicitation to Reconstitute the Board of Directors of Ziopharm Oncology Business Wire
08:00AM	REFILE-Ziopharm Oncology rebuffs investor's call for board seats Reuters
Oct-29-20 09:00AM	Ziopharm Oncology to Report Third Quarter 2020 Financial Results and Host a Conference Call and Webcast on November 5, 2020 GlobeNewswire
Oct-16-20 04:00PM	Ziopharm Oncology Announces Receipt of Shareholders Intent to Solicit Written Consents GlobeNewswire
Sep-30-20 06:26PM	Penny Stocks to Buy Using Technical Analysis for October 2020 Investopedia
Sep-23-20 01:48PM	Is ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) Popular Amongst Institutions? Simply Wall St. -6.44%
Sep-22-20 08:30AM	Ziopharm Oncology Appoints Kevin Buchi to its Board of Directors GlobeNewswire
Sep-15-20 08:30AM	Ziopharm Oncology Appoints Four Additional Members to Scientific Advisory Board GlobeNewswire +5.73%
Sep-14-20 04:17PM	Why Ziopharm Oncology Shares Zoomed Higher Today Motley Fool +12.50%
08:30AM	Ziopharm Oncology Granted Rare Pediatric Disease Designation for Controlled IL-12 for the Treatment of DIPG GlobeNewswire
Sep-10-20 09:00AM	Ziopharm Oncology to Participate in Upcoming Conferences GlobeNewswire
Sep-07-20 09:58AM	ZIOPHARM Oncology (ZIOP) Has Fallen 47% in Last One Year, Underperforms Market Insider Monkey
Aug-06-20 04:04PM	Ziopharm Oncology Reports Second Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Jul-28-20 09:00AM	Ziopharm Oncology to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020 GlobeNewswire -5.33%
Jul-22-20 08:30AM	Ziopharm Oncology Names James Huang to Board of Directors GlobeNewswire
Jul-10-20 07:25AM	The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs Benzinga
Jul-09-20 04:15PM	Ziopharm Oncology Announces Initiation of Phase 1 Trial Evaluating Rapid Personalized Manufacturing CAR-T Technology in Patients with Relapsed CD19+ Leukemias and Lymphomas GlobeNewswire
Jul-08-20 08:30AM	Ziopharm Oncology Doses First DIPG Patient in Phase 1/2 Trial of Controlled IL-12 for the Treatment of Pediatric Brain Tumors GlobeNewswire
Jun-30-20 11:47PM	ZIOPHARM Oncology Inc. (ZIOP): Are Hedge Funds Right About This Stock? Insider Monkey
Jun-22-20 09:48AM	Analysts: These 3 Penny Stocks May Very Well Be Worth the Risk TipRanks +8.56%
08:00AM	Ziopharm Oncology Completes Enrollment of Phase 2 Trial Evaluating Controlled IL-12 in Combination with Libtayo® in Patients with Glioblastoma GlobeNewswire
Jun-15-20 08:33AM	Do Options Traders Know Something About Ziopharm Oncology (ZIOP) Stock We Don't? Zacks +9.18%
08:00AM	Ziopharm Oncology Appoints Carl June, M.D., as Chairman of Scientific Advisory Board GlobeNewswire
Jun-12-20 09:00AM	Ziopharm Oncology to Participate in Cell Therapy Panel at the Raymond James Human Healthcare Innovation Conference on June 17, 2020 GlobeNewswire
06:09AM	Edited Transcript of ZIOP earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
May-29-20 08:00AM	Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2020 American Society of Clinical Oncology GlobeNewswire
May-27-20 04:15PM	Ziopharm Oncology Announces Management Transition GlobeNewswire +7.06%
08:30AM	Ziopharm Oncology to Present at the Jefferies 2020 Healthcare Conference on June 3, 2020 GlobeNewswire
May-11-20 02:50PM	Here's Why We're Not Too Worried About ZIOPHARM Oncology's (NASDAQ:ZIOP) Cash Burn Situation Simply Wall St.
May-08-20 04:00PM	Ziopharm Oncology Inc (ZIOP) Q1 2020 Earnings Call Transcript Motley Fool
09:00AM	Ziopharm Oncology to Present at the BofA Securities 2020 Health Care Conference GlobeNewswire
May-07-20 04:05PM	Ziopharm Oncology Reports First Quarter 2020 Financial Results and Provides Corporate Update GlobeNewswire
Apr-30-20 08:00AM	Ziopharm Oncology Announces Poster Presentations at the 2020 American Society of Clinical Oncology Virtual Meeting GlobeNewswire -8.20%
Apr-27-20 08:30AM	Ziopharm Oncology to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on May 7, 2020 GlobeNewswire +6.51%
Apr-06-20 06:00AM	Ziopharm- Catalysts in T-Cell Therapy MoneyShow +14.47%
Mar-04-20 12:37PM	Edited Transcript of ZIOP earnings conference call or presentation 2-Mar-20 9:30pm GMT Thomson Reuters StreetEvents +8.97%
Mar-02-20 04:05PM	Ziopharm Oncology Reports Financial Results for Fourth Quarter and Full Year 2019 GlobeNewswire
Feb-28-20 08:30AM	Ziopharm Oncology Presentation at the Barclays Global Healthcare Conference to be Webcast GlobeNewswire
Feb-24-20 08:30AM	Ziopharm Oncology to Host Conference Call to Discuss Fourth Quarter and Full Year 2019 Results on March 2, 2020 GlobeNewswire -5.76%
Feb-05-20 09:03AM	Ziopharm Oncology Announces Pricing of Public Offering of Common Stock GlobeNewswire -16.46%
07:43AM	The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data Benzinga
Feb-04-20 04:01PM	Ziopharm Oncology Announces Proposed Public Offering of Common Stock GlobeNewswire
Jan-30-20 08:45AM	Ziopharm Oncology Announces Recent Publications in Peer-Reviewed Scientific Journals GlobeNewswire
Dec-30-19 08:56AM	Options Traders Expect Huge Moves in ZIOPHARM Oncology (ZIOP) Stock Zacks -6.99%
Dec-19-19 08:45AM	Ziopharm Oncology Presentation at the 38th Annual J.P. Morgan Healthcare Conference to be Webcast GlobeNewswire
Dec-11-19 11:23AM	Hedge Funds Have Never Been This Bullish On ZIOPHARM Oncology Inc. (ZIOP) Insider Monkey
Dec-09-19 05:00PM	Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Dec-08-19 09:00AM	Ziopharm Oncology Presents Pre-Clinical Data Validating Rapid Personalized Manufacture (RPM) with TCR at the 2019 American Society for Hematology Annual Meeting GlobeNewswire
Dec-06-19 08:00AM	12 Biotech Stocks Primed For A Short Squeeze Benzinga
Nov-23-19 09:00AM	Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting GlobeNewswire
Nov-19-19 03:31PM	Edited Transcript of ZIOP earnings conference call or presentation 7-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-18-19 07:00AM	Ziopharm Oncology Updates Presentation and Webcast Time at the Jefferies 2019 London Healthcare Conference GlobeNewswire
Nov-11-19 09:10AM	Ziopharm Oncology Presentation at the Jefferies 2019 London Healthcare Conference to be Webcast GlobeNewswire -5.41%
Nov-07-19 04:05PM	Ziopharm Oncology Reports Third Quarter 2019 Financial Results GlobeNewswire
Oct-30-19 08:30AM	Ziopharm Oncology to Host Conference Call to Discuss Third Quarter 2019 Results on November 7, 2019 GlobeNewswire
Oct-28-19 06:06PM	Hedge Funds Have Never Been More Bullish On ZIOPHARM Oncology Inc. (ZIOP) Insider Monkey
08:00AM	Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program GlobeNewswire
Oct-18-19 06:00AM	Ziopharm Tests "Sleeping Beauty" for Oncology Treatment MoneyShow
Oct-15-19 08:00AM	Ziopharm Oncology Names Drug Development Leader Dr. Chris Bowden to Board of Directors GlobeNewswire
Oct-11-19 12:49PM	Jazz Starts CAR T-cell Linked Neurotoxicity Study Enrollment Zacks
Oct-01-19 08:00AM	Ziopharm Oncology Announces FDA Clearance of IND for Rapid Personalized Manufacture of CD19-specific CAR-T GlobeNewswire
Sep-30-19 06:45AM	MDNA.TO: Increased Overall Survival in rGBM Patients Seen with High Dose MDNA55 Zacks Small Cap Research
Sep-03-19 02:21PM	In expense-laden biotech industry, here are the Mass. startups most in need of cash American City Business Journals -5.01%
Aug-28-19 04:05PM	Ziopharm Oncology to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference GlobeNewswire +5.23%

ZIOPHARM Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown antigens. The company develops two immuno-oncology platform technologies, including Sleeping Beauty (SB), which is based on the genetic engineering of immune cells using a non-viral transposon/transposase system to reprogram T-cells outside of the body for infusion; and Controlled IL-12, which delivers interleukin 12 or IL-12, a master regular of the immune system, in a controlled and safe manner to focus the patient's immune system to attack cancer cells. It is developing Ad-RTS-hIL-12 plus veledimex, which is in Phase 2 clinical trial, to treat patients with recurrent glioblastoma multiforme in adults. The company is also developing chimeric antigen receptor (CAR) T-cell and T-cell receptor T-cell therapies. ZIOPHARM Oncology, Inc. has license agreement with Precigen, Inc. and MD Anderson Cancer Center; collaboration with MD Anderson targeting CD19 on malignant B cells using Sleeping Beauty platform; and research and development agreement with the National Cancer Institute to evaluate autologous peripheral blood lymphocytes, and Ares Trading S.A. The company was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Buck Jill	EVP, GM Gene Therapy	Jan 08	Sale	3.12	27,894	87,029	199,516	Jan 12 04:35 PM
Lafond Kevin G	SVP, Treasurer & CAO	Jan 08	Sale	3.09	18,020	55,682	63,965	Jan 12 04:34 PM
Hadfield Robert	General Counsel and Secretary	Jan 08	Sale	3.12	26,500	82,680	133,319	Jan 12 04:33 PM
De Groot Eleanor	EVP, GM Cell Therapy	Jan 04	Sale	2.72	21,620	58,806	206,413	Jan 06 05:03 PM
Cooper Laurence James Neil	President and CEO	Jan 04	Sale	2.71	105,693	286,428	1,799,280	Jan 06 05:02 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience